Clinical trial
A Pragmatic Randomized Controlled Trial to Evaluate the Efficacy and Safety of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Patients With Multidrug-resistant Tuberculosis in China
NCT05306223 is registered in ClinicalTrials.gov with Beijing Chest Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pragmatic Randomized Controlled Trial to Evaluate the Efficacy and Safety of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Patients With Multidrug-resistant Tuberculosis in China
- Lead sponsor
- Beijing Chest Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- May 10, 2022
- Completion date
- August 8, 2025
- Enrollment
- 212 (estimated)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.